K. Peony Yu's most recent trade in Staar Surgical Co. was a trade of 5,765 Common Stock Options done . Disclosure was reported to the exchange on June 16, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Staar Surgical Co. | K. Peony Yu | Director | 16 Jun 2022 | 5,765 | 5,765 | - | - | Common Stock Options | ||
Staar Surgical Co. | K. Peony Yu | Director | 16 Jun 2022 | 355 | 1,077 (0%) | 0% | 0 | Common Stock | ||
Staar Surgical Co. | K. Peony Yu | Director | 24 Jun 2021 | 850 | 850 | - | - | Common Stock Options | ||
Staar Surgical Co. | K. Peony Yu | Director | 24 Jun 2021 | 404 | 722 (0%) | 0% | 0 | Common Stock | ||
Staar Surgical Co. | K. Peony Yu | Director | 21 Jan 2021 | 684 | 684 | - | - | Common Stock Options | ||
Staar Surgical Co. | K. Peony Yu | Director | 21 Jan 2021 | 318 | 318 (0%) | 0% | 0 | Common Stock | ||
FibroGen Inc | K. Peony Yu | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 41.61 per share. | 16 Dec 2020 | 3,350 | 192,292 (0%) | 0% | 41.6 | 139,394 | Common Stock |
FibroGen Inc | K. Peony Yu | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.99 per share. | 07 Dec 2020 | 3,292 | 195,642 (0%) | 0% | 42.0 | 138,231 | Common Stock |
FibroGen Inc | K. Peony Yu | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 44.01 per share. | 16 Sep 2020 | 3,351 | 198,934 (0%) | 0% | 44.0 | 147,478 | Common Stock |
FibroGen Inc | K. Peony Yu | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.16 per share. | 08 Sep 2020 | 3,291 | 202,285 (0%) | 0% | 42.2 | 138,749 | Common Stock |
FibroGen Inc | K. Peony Yu | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 50.89 per share. | 03 Sep 2020 | 10,000 | 205,576 (0%) | 0% | 50.9 | 508,900 | Common Stock |
FibroGen Inc | K. Peony Yu | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2020 | 10,000 | 42,500 | - | - | Stock Option (Right to Buy) | |
FibroGen Inc | K. Peony Yu | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.00 per share. | 03 Sep 2020 | 10,000 | 215,576 (0%) | 0% | 18 | 180,000 | Common Stock |
FibroGen Inc | K. Peony Yu | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 42.35 per share. | 24 Jul 2020 | 3,351 | 205,576 (0%) | 0% | 42.4 | 141,915 | Common Stock |
FibroGen Inc | K. Peony Yu | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.61 per share. | 08 Jun 2020 | 3,292 | 208,927 (0%) | 0% | 33.6 | 110,644 | Common Stock |